Compound Radar

STERIS plc (STE) Stock Analysis

United States · Healthcare / Medical Devices

Price $218.44
Market cap $21.30B
Next earnings Nov 4, 2026
Entry status Watch $217.44–$224.59

Last updated Sep 8, 2026

Health Check

Last analyzed Sep 7, 2026

68
68/100 High Quality
  • Financial Health 75
  • Profitability 60
  • Business Quality 60
  • Balance Sheet 65
  • Cash Flow 80

Why this rating?

Health 68/100 — High Quality

Strongest Cash Flow 80/100
Softest Business Quality 60/100
Watch

Worth tracking, but timing is mixed — not a clear setup yet.

Company overview

STERIS plc (STE) is a Medical Devices company in the Healthcare sector. Compound Radar rates STERIS plc 68/100 (High Quality) due to solid business quality, steady revenue growth, and manageable leverage.

Investment profile

  • Quality Moderate
  • Growth Moderate
  • Balance Sheet Adequate
  • Valuation Attractive

Financial highlights

Valuation

  • P/E 26.7
  • Forward P/E 17.84
  • PEG 1.87
  • EV/Revenue 3.89

Profitability

  • Revenue Growth 7.3%
  • Gross Margin 44.4%
  • Operating Margin 19.2%
  • Net Margin 13.3%
  • ROE 11.4%

Financial strength

  • Cash $482.30M
  • Debt $2.04B
  • Net Cash $-1.56B
  • Free Cash Flow $972.40M
  • Current Ratio 1.91

Similar companies

Peers in Medical Devices, ranked by Financial Health.

Company Ticker
Price Current price

Latest quoted price for the name. Helps anchor the setup in today’s market level.

Health Entry

View all in Medical Devices →

FAQ

How Compound Radar scores and tracks STERIS plc (STE).

View Methodology & FAQ →